Loading organizations...
Loading organizations...
MyHealthPal develops an FDA-listed artificial intelligence platform designed for postoperative surgical site infection monitoring. This technology assesses wound health status and integrates patient-reported inputs to provide predictive risk alerts. The system assists clinicians in their decision-making processes by offering timely insights into potential complications following surgical procedures.
Information regarding the company's founders and specific founding insights is not readily available in public summaries. However, the development of such specialized AI-driven medical technology typically stems from a recognized need within healthcare for enhanced patient monitoring and proactive risk management in critical post-surgical recovery phases.
The platform serves clinicians and healthcare providers aiming to enhance patient outcomes through advanced monitoring capabilities. MyHealthPal’s vision centers on leveraging artificial intelligence to transform postoperative care, striving to reduce complications, improve recovery paths, and ultimately contribute to safer and more efficient patient management in hospitals and clinics.
MyHealthPal has raised $770K across 1 funding round.
MyHealthPal has raised $770K in total across 1 funding round.
MyHealthPal has raised $770K in total across 1 funding round.
MyHealthPal's investors include Andrew MacKay, Will Armitage, Terence Bradley, Proxy Ventures.
MyHealthPal is a technology company that builds a digital companion platform designed to help people with long-term health conditions manage their symptoms, medication, and overall health. Initially focused on Parkinson’s disease, it aggregates patient data such as symptoms, mood, diet, and exercise into an analytics dashboard for both patients and medical researchers. The platform also enables users to anonymously share their data with research institutions in exchange for revenue sharing, creating a novel "share economy for patients" model. Additionally, MyHealthPal offers AI-driven postoperative monitoring technology to predict and prevent surgical site infections, facilitating remote patient-physician communication and improving recovery outcomes. This dual focus serves patients managing chronic conditions and postoperative care, addressing gaps in symptom tracking, medication effectiveness, and early complication detection[1][2][4][5].
MyHealthPal was founded by Mike Barlow, a technologist diagnosed with Parkinson’s disease at age 41, who developed the platform out of personal necessity due to the lack of effective tools to track medication impact and symptoms. The company launched out of stealth in 2015 and secured seed funding of £500,000. It began clinical trials with Mount Sinai Hospital’s Movement Disorder Clinic in New York, under the guidance of leading neurologists. The idea emerged from Barlow’s firsthand experience and desire to empower patients with better health management tools. Separately, the postoperative monitoring technology was developed by Predictive Healthcare, a Boston-based company founded in 2021, leveraging AI and machine learning to enhance surgical recovery and reduce infection risks[1][2][5].
MyHealthPal rides the growing trend of digital health and personalized medicine, leveraging big data, AI, and remote monitoring to transform chronic disease management and postoperative care. The timing is critical as healthcare systems increasingly adopt telehealth and data-driven approaches to improve outcomes and reduce costs. Market forces such as aging populations, rising chronic disease prevalence, and demand for patient-centered care favor platforms that empower patients and provide actionable insights to clinicians. By enabling data sharing with research institutions, MyHealthPal also contributes to accelerating medical research and innovation. Its dual focus on chronic condition management and surgical recovery positions it uniquely within the expanding digital health ecosystem[1][2][4][5].
Looking ahead, MyHealthPal is poised to expand its clinical trials and partnerships, potentially broadening its platform to cover more chronic diseases and surgical applications. Advances in AI and machine learning will likely enhance its predictive capabilities and patient engagement features. The company’s innovative data-sharing revenue model could set a precedent for patient involvement in health data economies. As healthcare continues to digitize, MyHealthPal’s integration of patient-generated data with clinical workflows and research could significantly influence personalized medicine and remote care standards. Its growth momentum, backed by clinical validation and a patient-first approach, suggests a promising trajectory in the evolving healthcare technology landscape[1][2][4][5].
MyHealthPal has raised $770K across 1 funding round. Most recently, it raised $770K Seed in February 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2015 | $770K Seed | Andrew MacKay, Will Armitage | Terence Bradley, Proxy Ventures |